252 related articles for article (PubMed ID: 16076955)
21. Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance.
McNeil EM; Astell KR; Ritchie AM; Shave S; Houston DR; Bakrania P; Jones HM; Khurana P; Wallace C; Chapman T; Wear MA; Walkinshaw MD; Saxty B; Melton DW
DNA Repair (Amst); 2015 Jul; 31():19-28. PubMed ID: 25956741
[TBL] [Abstract][Full Text] [Related]
22. DNA-binding polarity of human replication protein A positions nucleases in nucleotide excision repair.
de Laat WL; Appeldoorn E; Sugasawa K; Weterings E; Jaspers NG; Hoeijmakers JH
Genes Dev; 1998 Aug; 12(16):2598-609. PubMed ID: 9716411
[TBL] [Abstract][Full Text] [Related]
23. The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif.
Enzlin JH; Schärer OD
EMBO J; 2002 Apr; 21(8):2045-53. PubMed ID: 11953324
[TBL] [Abstract][Full Text] [Related]
24. The C-terminal region of the Escherichia coli UvrC protein, which is homologous to the C-terminal region of the human ERCC1 protein, is involved in DNA binding and 5'-incision.
Moolenaar GF; Uiterkamp RS; Zwijnenburg DA; Goosen N
Nucleic Acids Res; 1998 Jan; 26(2):462-8. PubMed ID: 9421501
[TBL] [Abstract][Full Text] [Related]
25. The HhH domain of the human DNA repair protein XPF forms stable homodimers.
Das D; Tripsianes K; Jaspers NG; Hoeijmakers JH; Kaptein R; Boelens R; Folkers GE
Proteins; 2008 Mar; 70(4):1551-63. PubMed ID: 17912758
[TBL] [Abstract][Full Text] [Related]
26. The Cerebro-oculo-facio-skeletal Syndrome Point Mutation F231L in the ERCC1 DNA Repair Protein Causes Dissociation of the ERCC1-XPF Complex.
Faridounnia M; Wienk H; Kovačič L; Folkers GE; Jaspers NG; Kaptein R; Hoeijmakers JH; Boelens R
J Biol Chem; 2015 Aug; 290(33):20541-55. PubMed ID: 26085086
[TBL] [Abstract][Full Text] [Related]
27. Targeting DNA Repair in Tumor Cells via Inhibition of ERCC1-XPF.
Elmenoufy AH; Gentile F; Jay D; Karimi-Busheri F; Yang X; Soueidan OM; Weilbeer C; Mani RS; Barakat KH; Tuszynski JA; Weinfeld M; West FG
J Med Chem; 2019 Sep; 62(17):7684-7696. PubMed ID: 31369707
[TBL] [Abstract][Full Text] [Related]
28. Fluorescence-based incision assay for human XPF-ERCC1 activity identifies important elements of DNA junction recognition.
Bowles M; Lally J; Fadden AJ; Mouilleron S; Hammonds T; McDonald NQ
Nucleic Acids Res; 2012 Jul; 40(13):e101. PubMed ID: 22457069
[TBL] [Abstract][Full Text] [Related]
29. An archaeal endonuclease displays key properties of both eukaryal XPF-ERCC1 and Mus81.
Roberts JA; White MF
J Biol Chem; 2005 Feb; 280(7):5924-8. PubMed ID: 15591065
[TBL] [Abstract][Full Text] [Related]
30. The structure-specific endonuclease Ercc1-Xpf is required for targeted gene replacement in embryonic stem cells.
Niedernhofer LJ; Essers J; Weeda G; Beverloo B; de Wit J; Muijtjens M; Odijk H; Hoeijmakers JH; Kanaar R
EMBO J; 2001 Nov; 20(22):6540-9. PubMed ID: 11707424
[TBL] [Abstract][Full Text] [Related]
31. The ERCC1 and ERCC4 (XPF) genes and gene products.
Manandhar M; Boulware KS; Wood RD
Gene; 2015 Sep; 569(2):153-61. PubMed ID: 26074087
[TBL] [Abstract][Full Text] [Related]
32. Mouse SLX4 is a tumor suppressor that stimulates the activity of the nuclease XPF-ERCC1 in DNA crosslink repair.
Hodskinson MR; Silhan J; Crossan GP; Garaycoechea JI; Mukherjee S; Johnson CM; Schärer OD; Patel KJ
Mol Cell; 2014 May; 54(3):472-84. PubMed ID: 24726326
[TBL] [Abstract][Full Text] [Related]
33. The Fanconi anemia protein, FANCG, binds to the ERCC1-XPF endonuclease via its tetratricopeptide repeats and the central domain of ERCC1.
Wang C; Lambert MW
Biochemistry; 2010 Jul; 49(26):5560-9. PubMed ID: 20518486
[TBL] [Abstract][Full Text] [Related]
34. DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy.
McNeil EM; Melton DW
Nucleic Acids Res; 2012 Nov; 40(20):9990-10004. PubMed ID: 22941649
[TBL] [Abstract][Full Text] [Related]
35. The 3'-flap endonuclease XPF-ERCC1 promotes alternative end joining and chromosomal translocation during B cell class switching.
Bai W; Zhu G; Xu J; Chen P; Meng F; Xue H; Chen C; Dong J
Cell Rep; 2021 Sep; 36(13):109756. PubMed ID: 34592150
[TBL] [Abstract][Full Text] [Related]
36. DCAF7 is required for maintaining the cellular levels of ERCC1-XPF and nucleotide excision repair.
Kawara H; Akahori R; Wakasugi M; Sancar A; Matsunaga T
Biochem Biophys Res Commun; 2019 Oct; 519(1):204-210. PubMed ID: 31493872
[TBL] [Abstract][Full Text] [Related]
37. Replication protein A confers structure-specific endonuclease activities to the XPF-ERCC1 and XPG subunits of human DNA repair excision nuclease.
Matsunaga T; Park CH; Bessho T; Mu D; Sancar A
J Biol Chem; 1996 May; 271(19):11047-50. PubMed ID: 8626644
[TBL] [Abstract][Full Text] [Related]
38. Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?
Bergstralh DT; Sekelsky J
Trends Genet; 2008 Feb; 24(2):70-6. PubMed ID: 18192062
[TBL] [Abstract][Full Text] [Related]
39. XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF.
Lehmann J; Seebode C; Smolorz S; Schubert S; Emmert S
Cell Mol Life Sci; 2017 Jun; 74(11):2081-2094. PubMed ID: 28130555
[TBL] [Abstract][Full Text] [Related]
40. Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
Ahmad A; Enzlin JH; Bhagwat NR; Wijgers N; Raams A; Appledoorn E; Theil AF; J Hoeijmakers JH; Vermeulen W; J Jaspers NG; Schärer OD; Niedernhofer LJ
PLoS Genet; 2010 Mar; 6(3):e1000871. PubMed ID: 20221251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
